| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.26 | 2e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.23 | 5e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.21 | 0.0007 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.009 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.05 |